Trial Profile
Efficacy and tolerability of artemether/lumefantrine and dihydroartemisinin/piperaquine in nigerian patients with uncomplicated plasmodium falciparum.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2015
Price :
$35
*
At a glance
- Drugs Artemether/lumefantrine (Primary) ; Dihydroartemisinin/piperaquine
- Indications Falciparum malaria
- Focus Therapeutic Use
- 05 Nov 2015 New trial record